Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-04-02 Sale |
2025-04-04 7:27 pm |
Monopar Therapeutics | MNPR | Tactic Pharma LLC Robinson Chandler Brown Michael J O'Halloran Thomas V. Mazar Andrew Paul 10% Owner |
33,334 | $35 | $1,166,690 | 822,255 (Direct) |
View |
2024-10-28 Purchase |
2024-10-30 4:17 pm |
Monopar Therapeutics | MNPR | Radhakrishnan Karthik Chief Financial Officer |
1,550 | $16.25 | $25,188 | 1,550 (Direct) |
View |
2024-06-18 Purchase |
2024-06-21 5:16 pm |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
32,508 | $0.78669 | $25,574 | 186,132 (Direct) |
View |
2024-06-13 Purchase |
2024-06-17 6:08 pm |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
36,000 | $0.91373 | $32,894 | 153,624 (Direct) |
View |
2024-06-03 Purchase |
2024-06-05 6:12 pm |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
24,000 | $0.77 | $18,480 | 117,624 (Direct) |
View |
2024-05-29 Purchase |
2024-05-31 4:56 pm |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
36,000 | $0.6403 | $23,051 | 93,624 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-03-31 Exercise |
2025-04-02 9:08 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
3,582 | $0 | 91,849 (Direct) |
View |
2025-03-31 Tax Withholding |
2025-04-02 9:08 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
744 | $36.41 | 91,849 (Direct) |
View |
2025-03-31 Exercise |
2025-04-02 9:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
4,106 | $0 | 1,016,251 (Direct) |
View |
2025-03-31 Tax Withholding |
2025-04-02 9:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
1,204 | $36.41 | 1,016,251 (Direct) |
View |
2025-03-04 Exercise |
2025-03-07 9:24 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
6,002 | $0 | 1,207,991 (Direct) |
View |
2025-03-04 Option Award |
2025-03-07 9:24 pm |
N/A 2035-03-04 |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
165,658 | $0 | 1,207,991 (Direct) |
View |
2025-03-04 Tax Withholding |
2025-03-07 9:24 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
1,759 | $31.7 | 1,207,991 (Direct) |
View |
2025-03-04 Option Award |
2025-03-07 9:09 pm |
N/A 2035-03-04 |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
84,026 | $0 | 95,100 (Direct) |
View |
2025-03-04 Option Award |
2025-03-07 8:14 pm |
N/A 2035-03-04 |
Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director |
11,365 | $0 | 11,365 (Direct) |
View |
2025-03-04 Option Award |
2025-03-07 7:58 pm |
N/A 2035-03-04 |
Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director |
11,365 | $0 | 11,365 (Direct) |
View |
2025-03-04 Option Award |
2025-03-07 7:55 pm |
N/A 2035-03-04 |
Monopar Therapeutics | MNPR | Anderson Raymond Director |
11,365 | $0 | 11,365 (Direct) |
View |
2025-03-04 Option Award |
2025-03-07 7:51 pm |
N/A 2035-03-04 |
Monopar Therapeutics | MNPR | Talukdar Lavina Director |
5,683 | $0 | 5,683 (Direct) |
View |
2025-03-04 Option Award |
2025-03-07 7:48 pm |
N/A 2035-03-04 |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director |
11,365 | $0 | 11,365 (Direct) |
View |
Ownership |
2025-03-06 7:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Talukdar Lavina Director |
0 | $0 | 14,001 (Direct) |
View |
2025-03-03 Option Award |
2025-03-05 4:06 pm |
N/A 2035-03-02 |
Monopar Therapeutics | MNPR | Vu Quan Anh Chief Financial Officer |
25,000 | $0 | 25,000 (Direct) |
View |
2025-01-01 Option Award |
2025-01-02 6:16 pm |
N/A 2034-12-31 |
Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer |
2,000 | $0 | 2,000 (Direct) |
View |
2024-12-31 Exercise |
2025-01-02 6:15 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
1,790 | $0 | 52,012 (Direct) |
View |
2024-12-31 Tax Withholding |
2025-01-02 6:15 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
721 | $22 | 52,012 (Direct) |
View |
2024-12-31 Exercise |
2025-01-02 6:14 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
4,895 | $0 | 939,316 (Direct) |
View |
2024-12-31 Tax Withholding |
2025-01-02 6:14 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
2,209 | $22 | 939,316 (Direct) |
View |
2024-12-09 Other |
2024-12-17 4:57 pm |
N/A N/A |
Monopar Therapeutics | MNPR | TacticGem LLC 10% Owner |
1,433,334 | $0 | 1,433,334 (Direct) |
View |
2024-09-30 Exercise |
2024-10-02 7:45 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
4,895 | $0 | 941,525 (Direct) |
View |
2024-09-30 Tax Withholding |
2024-10-02 7:45 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
1,918 | $6.74 | 941,525 (Direct) |
View |
2024-09-30 Exercise |
2024-10-02 7:44 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
1,791 | $0 | 52,733 (Direct) |
View |
2024-09-30 Tax Withholding |
2024-10-02 7:44 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
535 | $6.74 | 52,733 (Direct) |
View |
2024-07-01 Option Award |
2024-07-03 6:22 pm |
N/A 2034-06-30 |
Monopar Therapeutics | MNPR | Radhakrishnan Karthik Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
2024-06-30 Exercise |
2024-07-02 6:12 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
8,952 | $0 | 266,336 (Direct) |
View |
2024-06-30 Tax Withholding |
2024-07-02 6:12 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
2,019 | $0.731 | 266,336 (Direct) |
View |
2024-06-30 Exercise |
2024-07-02 6:08 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
9,957 | $0 | 131,841 (Direct) |
View |
2024-06-30 Tax Withholding |
2024-07-02 6:08 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
2,998 | $0.731 | 131,841 (Direct) |
View |
2024-06-30 Exercise |
2024-07-02 6:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
24,476 | $0 | 4,717,198 (Direct) |
View |
2024-06-30 Tax Withholding |
2024-07-02 6:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
8,684 | $0.731 | 4,717,198 (Direct) |
View |
2024-05-28 Exercise |
2024-05-30 6:10 pm |
N/A 2026-04-03 |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
84,000 | $0 | 4,528,071 (Direct) |
View |
2024-05-28 Exercise |
2024-05-30 6:10 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
84,000 | $0.001 | 4,528,071 (Direct) |
View |
2024-05-22 Option Award |
2024-05-24 4:59 pm |
N/A 2034-05-22 |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
25,000 | $0 | 25,000 (Direct) |
View |
2024-03-31 Exercise |
2024-04-02 8:35 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
8,952 | $0 | 139,847 (Direct) |
View |
2024-03-31 Tax Withholding |
2024-04-02 8:35 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
3,098 | $0.681 | 139,847 (Direct) |
View |
2024-03-31 Exercise |
2024-04-02 8:33 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
9,956 | $0 | 134,839 (Direct) |
View |
2024-03-31 Tax Withholding |
2024-04-02 8:33 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
4,082 | $0.681 | 134,839 (Direct) |
View |
2024-03-31 Exercise |
2024-04-02 8:33 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
24,474 | $0 | 4,641,882 (Direct) |
View |
2024-03-31 Tax Withholding |
2024-04-02 8:33 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
7,172 | $0.681 | 4,641,882 (Direct) |
View |
2023-12-31 Exercise |
2024-01-03 7:40 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Anderson Raymond Director |
2,533 | $0 | 26,863 (Direct) |
View |
2023-12-31 Exercise |
2024-01-03 7:40 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Brown Michael J Director |
2,533 | $0 | 4,513,803 (Direct) |
View |
2023-12-31 Exercise |
2024-01-03 7:39 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
8,952 | $0 | 142,945 (Direct) |
View |
2023-12-31 Tax Withholding |
2024-01-03 7:39 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
3,098 | $0.3402 | 142,945 (Direct) |
View |
2023-12-31 Exercise |
2024-01-03 7:38 pm |
N/A N/A |
Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director |
2,533 | $0 | 3,086,257 (Direct) |
View |
2023-12-31 Exercise |
2024-01-03 7:37 pm |
N/A N/A |
Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director |
2,533 | $0 | 75,263 (Direct) |
View |
2023-12-31 Exercise |
2024-01-03 7:36 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
31,198 | $0 | 9,156,003 (Direct) |
View |
2023-12-31 Tax Withholding |
2024-01-03 7:36 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
10,796 | $0.3402 | 9,156,003 (Direct) |
View |